← Browse by Condition
Medical Condition

biomarkers

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for biomarkers sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — biomarkers Clinical Trials

How many clinical trials are currently recruiting for biomarkers?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for biomarkers, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for biomarkers?
biomarkers research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a biomarkers clinical trial?
Eligibility criteria for biomarkers trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Shanghai Mental Health Center 1 trial
Centre Hospitalier Universitaire, Amiens 1 trial
University of Galway 1 trial

Recruiting Clinical Trials

NCT06680011
Recruiting
Cohort-Based Study of Diagnostic Biomarkers for Neurosyphilis
Enrollment
360 pts
Location
China
Sponsor
Shanghai Mental Health Center
View Trial →
NCT07071649
Recruiting
Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer's Disease, and Comparison With CSF Markers
Enrollment
40 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT07577609
Recruiting
AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)
Enrollment
10,000 pts
Location
Ireland
Sponsor
University of Galway
View Trial →

Related Conditions

neurosyphilis (1) proteomics (1) alzheimer s disease (1) non invasive diagnosis (1) phosphorylated protein p tau217 (1) coronary artery disease cad (1) computed tomography angiography (1) ai artificial intelligence (1) lipoprotein a (1) atheroscleroses coronary (1) myocardial ischemia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology